BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190121
DTEND;VALUE=DATE:20190123
DTSTAMP:20260515T001028
CREATED:20171019T063411Z
LAST-MODIFIED:20180831T072922Z
UID:3491-1548028800-1548201599@www.pharmajournalist.com
SUMMARY:Social Media in the Pharmaceutical Industry
DESCRIPTION:SMi Group are delighted to present the return of their 11th annual Social Media in the Pharmaceutical Industry conference to London on the 21st– 23rd January 2019. \n \nSocial media is the perfect channel for pharmaceutical companies to educate\, market\, listen and connect with customers\, patients and physicians. How the pharmaceutical industry utilize social media is particularly complex as regulators such as the FDA have not yet written the rules about how pharmaceuticals can engage with potential customers and patients. \nJoin SMi’s 11th annual Social Media in the Pharmaceutical Industry conference to learn the best way your company can benefit froma robust social media strategy. Hear from industry experts on how to leverage social media platforms by keeping the patient at the forefront and exploring the latest advances in digital application such as Artificial Intelligence\, challenges and techniques in the field of ‘social pharma’. \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \n\n[CHAIR] – Jason Browning\, Global Head of Digital Communications & Social Media\, Novartis\n[CHAIR] – Emma Sutcliffe\, Director Patient Engagement and Innovation\, NexGen Healthcare Communications\nRoeland Van der Heiden\, Digital Director\, AstraZeneca\nLin Lei\, Associate Director Digital Customer Engagement\, Teva\nJoao Bocas\, CEO\, DigitalSalutem\nPaul Tunnah\, CEO\, PharmaPhorumMedia\nJacob D Flindt\, Founder\, pro\nAlan Shaw\, Director\, Strategic Planet; Senior Lecturer: Digital Marketing\, Northumbria University\nDennis Fink\, Campaign Manager and Social Media Channel Expert\, Qiagen\nStefania Alvino\, Multichannel Manager\, Daiichi Sankyo Co.\, Ltd.\n\n2019 Featured Highlights: \n\nExplore a result driven\, value focused social media strategy in the pharmaceutical industry\nGain insight into procedures and practices required prior to the implementation of social listening\nDiscuss how to personalise the content relationships with AI\nUnderstand the optimisation of disease awareness through social media channels\nLearn how to use social networks and digital communication to engage HCPs\nGDPR regulations and limitations to product advertisement (with case studies)\nPharmacovigilance in social media – specifically in adverse events reporting\n\nCheck out the brochure online: www.social-media-pharma.com/pj \nEarly-Bird Rates \n\nREGISTER BY 29TH SEPTEMBER AND SAVE £400\nREGISTER BY 31ST OCTOBER AND SAVE £200\nREGISTER BY 30TH NOVEMBER AND SAVE £100
URL:https://www.pharmajournalist.com/event/social-media-pharmaceutical-industry/
LOCATION:Holiday Inn London – Kensington Forum
ORGANIZER;CN="SMi Group Ltd":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190121
DTEND;VALUE=DATE:20190123
DTSTAMP:20260515T001028
CREATED:20180906T115651Z
LAST-MODIFIED:20180906T115737Z
UID:17521-1548028800-1548201599@www.pharmajournalist.com
SUMMARY:SMi’s 8th Annual Pharmaceutical Microbiology
DESCRIPTION:SMi’s 8th Annual Pharmaceutical Microbiology: Addressing the key challenges\, trends and strategies in contamination control  \nConference: 21st & 22nd January 2019\nWorkshop: 23rd January 2019\nLocation: Copthorne Tara Hotel\, London\, UK\nWebsite: http://www.pharma-microbiology.com/PharmaJournWL \nSPONSORED BY: GOLD SPONSOR: DuPont; SPONSORS: Mettler Toledo\, Biomerieux and Copan Group  \nCHAIRED BY:\nJames Drinkwater\, Chairman\, Pharmaceutical & Healthcare Sciences Society\nOlivier Chancel\, Sterility and Aseptic Process Assurance\, Expert\, Boehringer Ingelheim \n \nThe pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods\, revisions being made to regulations in the industry\, enhanced knowledge of the human microbiome\, and novel testing methods\, this industry is ever expanding. In fact\, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022\, expanding at a CAGR of 7.3% from 2016 to 2022. This is the 8th year of a conference which is continually run by SMi and which has been very successful over the past few years. \nDeveloping on last years’ success\, Pharmaceutical Microbiology UK 2019 will bring together industry experts to discuss and analyse the latest advancement and challenges within pharmaceutical microbiology. Discover how you can keep up with regulatory changes and maintain the utmost efficiency during production and testing.  \nEvent Hashtag: #PharmaMicro \nAt the 8th Annual Pharmaceutical Microbiology Conference\, you will gain insight into: \n\nChallenges in development of a contamination control strategy for different product types\nA series of learning experiences within contamination from Boehringer Ingelheim\nThe use of vaporized hydrogen peroxide bio-decontamination technology in microbiology contamination control\nCase studies in deinococcus and fungal and bacterial spores in cleanrooms\nInfluence of temperature of incubation on results of microbiological environmental monitoring\nRisk mitigation strategies for animal-derived raw materials\n\nFEATURED SPEAKERS INCLUDE: \n\nAlexander Stoll\, VP Competence Center Microbiology & Aseptic Technique Quality Management\, Fresenius Kabi\nDi Morris\, Senior Manager\, Team Leader\, Vaccines Quality Audit\, GSK\nMarine Marius\, Scientist\, Analytical Research & Development Europe\, Sanofi Pasteur\nPhilippe Dutot\, Sterility Assurance Specialist\, Novo Nordisk\nRenate Rosengarten\, Professor and Chair of Bacteriology and Hygiene\, University of Veterinary Medicine Vienna\nThierry Bonnevay\, Microbiology Platform Head\, Analytical Research and Development\, Sanofi Pasteur\nTim Eaton\, Sterile Manufacturing Specialist\, AstraZeneca \n\nKEY TOPICS FOR 2018 INCLUDE: \n\nRapid Microbial Methods\nRevision of Annex 1 and impact on pharmaceutical microbiology\nContamination control strategies and case studies\nMycoplasma detection\, prevention and control\nFuture of endotoxin testing in pharmaceutical industries\nStrengths and weaknesses of vaporized Hydrogen peroxide as a bio-contamination control agent\nMold contamination control\nInfluence of temperature of incubation on results of microbiological environmental monitoring\n\nWHO SHOULD ATTEND \nSenior Microbiologist\, Lead Scientist\, Laboratory Manager\, QA Specialist Drug Substance External Manufacturer\, Business Development Manager – Testing\, Pharmaceutical Microbiology Consultant\, Higher Pharmacopoeia Scientist\, Analytical Standards Specialist \nEARLY BIRD-RATES \n\nBOOK BY 28TH SEPTEMBER AND SAVE £400\nBOOK BY 31ST OCTOBER AND SAVE £200\nBOOK BY 30TH NOVEMBER AND SAVE £100\n\nTo learn more about this event\, and to register online\, visit http://www.pharma-microbiology.com/PharmaJournWL
URL:https://www.pharmajournalist.com/event/8th-annual-pharmaceutical-microbiology/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
END:VCALENDAR